Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Best e-Business Site, 2006
Best e-Business Site, 2007
Amazon’s Alexa 2008 PageRank: #2 News and Media Site for the Pharmaceutical Industry
Google 2008 PageRank: #3 Among Top Health News and Media Publications
NewsRx also is available at Factiva, LexisNexis, ProQuest, Westlaw, Dialog, NewsEdge, InfoDesk, and Dow Jones.

Medical News Article on Arthritis



Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis



2008 MAY 5 -- Latona Life Sciences Inc. (Latona) announced that it has entered into two agreements for the acquisition of patent rights and orphan drug status to a novel late-stage drug, trademarked "Oralgam," for the treatment of Juvenile and Adult Rheumatoid Arthritis.

Latona has entered into a licensing agreement to acquire the patent rights to Oralgam with Research Corporation Technologies, Inc., of Tucson, Arizona. Under the terms of this agreement, Latona will acquire the exclusive worldwide rights to Oralgam for the treatment of Adult Rheumatoid Arthritis and the treatment of auto-immune induced hearing loss.

Latona has also entered into...

In order to view the entire article, please read your options to the right

Price: $3.00


NewsRx Customer? If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.

Email:
Password:

New to NewsRx? If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.

Purchase a NewsRx Pass
View an unlimited number of articles for a day, week, month, etc.

Purchase NewsRx Bundled
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!